FIELD: pharmacology.
SUBSTANCE: invention is a dermatological composition containing dapsone, the first solubilising agent, which is monoethyl ether diethylene glycol, polymer thickener and water, where dapsone is present in the composition at a concentration of 3 wt % to 10 wt % and the polymer thickener consists of a acrylamide/sodium acryloyldimethyltaurate copolymer.
EFFECT: reduced particle size of dapsone, which leads to minimized feeling of the presence of sand when applied, and decreased dapsone dissolution in the monoethyl ether of diethylene glycol that leads to a more aesthetic appearance of the composition.
19 cl, 3 dwg, 8 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMEDOLYTIC PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT | 2012 |
|
RU2530644C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING ACNE AND METHOD FOR PREPARING IT | 2012 |
|
RU2548714C2 |
COMPOSITIONS FOR LOCAL APPLICATION CONTAINING BIMATOPROST, AND METHODS FOR HAIR GROWTH STIMULATION WITH HELP THEREOF | 2014 |
|
RU2703713C2 |
GALENIC COMPOSITION CONTAINING A DRUG FOR TOPICAL APPLICATION | 2016 |
|
RU2699022C1 |
APPLICATOR SYSTEM FOR VISCOUS LIQUID APPLICATION TO HUMAN SKIN | 2012 |
|
RU2634638C2 |
TESTOSTERONE COMPOSITIONS | 2012 |
|
RU2613891C2 |
TETRACYCLIN COMPOSITIONS FOR TOPICAL APPLICATION, THEIR PRODUCTION AND APPLICATION | 2013 |
|
RU2639591C2 |
NON-STAINING GEL COMPOSITION CONTAINING NIMESULIDE, FOR TOPICAL APPLICATION | 2016 |
|
RU2711090C2 |
COMPOSITION FOR TOPICAL APPLICATION CONTAINING GLYCERIN AND YEAST EXTRACT | 2019 |
|
RU2801139C2 |
ORGANOGEL COMPOSITIONS FOR THERAPEUTIC APPLICATION | 2005 |
|
RU2422132C2 |
Authors
Dates
2017-12-15—Published
2013-11-18—Filed